Reflux: Clinical Trials

3 trials for Reflux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Reflux: new trials by email Literature Review of Reflux trials Research Report on Reflux

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
Quercetin - Gastroesophageal Reflux Disease, GERD
Phase 1CompletedUniversity of North Carolina, Chapel Hill262014-08-012016-12-20
Renal Impairment Study
AZD3355 - Reflux, Renal Excretion
Phase 1CompletedAstraZeneca232009-03-012011-01-24
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
esomeprazole magnesium - Endoscopically-Proven GERD, Reflux
Phase 1CompletedAstraZeneca402006-08-012008-06-11

Narrower conditions

Gastroesophageal Reflux (3)

Broader conditions

Deglutition Disorders (3)  ·  Digestive System Diseases (3)  ·  Esophageal Diseases (3)  ·  Esophageal Motility Disorders (3)  ·  Gastrointestinal Diseases (3)

Interventions

Esomeprazole (1)  ·  Quercetin (1)  ·  lesogaberan (1)

Sponsors

AstraZeneca (2)  ·  University of North Carolina, Chapel Hill (1)

Countries

Sweden (1)  ·  United States (1)

Top investigators

Lynne Durborow (1)  ·  Marta Illueca (1)  ·  Nicholas Shaheen, MD, MPH (1)  ·  Wolfgang Kuhn, MD (1)

Results publications

PMID 27875488

NIH funding

R21DK097529 (1)